BBIO - bridgebio shares phase 2 data for infigratinib in achondroplasia March, 06 2023 01:03 PM BridgeBio Pharma Inc. 2023-03-06 13:03:55 ET The following slide deck was published by BridgeBio Pharma, Inc. in conjunction with this event. For further details see: bridgebio shares phase 2 data for infigratinib in achondroplasia